Professor Paul Glasziou is Director of the Institute for Evidence-Based Healthcare at Bond University and was the Director of the Centre for Evidence-Based Medicine in Oxford from 2003-2010. His key interests include identifying and removing barriers to using high quality research in everyday clinical practice and improving the clinical impact of research by reducing the more than $85 Billion annual loss from unpublished and unusable research (Chalmers. Glasziou. Lancet 2009). He co-founded the International Society for Evidence-based Health Care and the RACGP's Handbook of Non-Drug Interventions. He has authored over 600 peer-reviewed journal articles and 7 books.

Gordon Guyatt is a McMaster University Distinguished Professor. His work. focused on Evidence-based Medicine. has resulted in over 1.500 peer-reviewed publications cited over 175.000 times - making him one of the world’s 20 most cited researchers – and had a profound impact on medical practice worldwide.

John P.A. Ioannidis. MD. DSc is Professor of Medicine. of Epidemiology and Population Health. and (by courtesy) of Biomedical Data Science and of Statistics and Co-Director. Meta-Research Innovation Center at Stanford (METRICS) at Stanford University. Born in New York City in 1965 and raised in Athens. Greece. Valedictorian (1984) at Athens College; National Award of the Greek Mathematical Society (1984); MD (top rank of medical school class) from the National University of Athens (1990); also received DSc in biopathology from the same institution. Trained at Harvard and Tufts (internal medicine. Infectious diseases). then held positions at NIH. Johns Hopkins and Tufts. Chaired the Department of Hygiene and Epidemiology. University of Ioannina Medical School in 1999-2010 while also holding adjunct professor positions at Harvard. Tufts. and Imperial College. Senior Advisor on Knowledge Integration at NCI/NIH (2012-6). President Elect. Association of American Physicians (2022). Served as President. Society for Research Synthesis Methodology and Editor-in-Chief of European Journal of Clinical Investigation (2010-2019). Delivered ~700 invited and honorary lectures. European Award for Excellence in Clinical Science [2007]. Medal for Distinguished Service. Teachers College. Columbia U [2015]. Chanchlani Global Health Award [2017]. Epiphany Science Courage Award [2018]. Einstein fellow [2018]. Gordon award [2019]. Albert Stuyvenberg Medal (2021). Harwood Prize [2022]). Inducted in Association of American Physicians (2009). European Academy of Cancer Sciences (2010) American Epidemiological Society (2015). European Academy of Sciences and Arts (2015). National Academy of Medicine (2018). Accademia delle Scienze (Bologna) (2021). Honorary titles from FORTH (2014) and Ioannina (2015). honorary doctorates from Rotterdam (2015). Athens (2017). Tilburg (2019). Edinburgh (2021). h=237 (Google Scholar). current citation rate: >6.000 new citations per month (among the 6 scientists worldwide who are currently the most commonly cited).

Dr. Eleanor Ochodo-Opondo is a medical doctor and research scientist. She currently holds a joint appointment as a Research Scientist at the Kenya Medical Research Institute and Associate Professor Extraordinary of Clinical Epidemiology at the Centre for Evidence-based Health Care. Department of Global Health. in Stellenbosch University. South Africa. Her research interests revolve around evidence-based health care with a focus on diagnostic tests-their accuracy. impact and how their results can be translated to policy and practice. She serves as a methodologist/consultant to the World Health Organization (WHO) conducting systematic reviews to inform WHO guidelines on HIV and TB diagnostic testing and developing guidance on screening for epidemic prone diseases including COVID-19. The National Research Foundation of South Africa recognized her as a promising young researcher in 2018 and nominated her for the 2020 Annual HOPE meeting with Nobel Laureates.
She was recently awarded the prestigious 2019 UK MRC/DFID African Research Leader award and 2020 UK NIHR developmental award to advance the science of evidence synthesis and research translation in Africa focusing on collaboration between South Africa. Kenya and Liverpool School of Tropical Medicine in the UK. She serves as an academic editor with the Cochrane collaboration (infectious diseases group) and is a section editor with PLOS Global Public Health. She supervises MSc and PhD students in Kenya and South Africa and is currently a Commissioner in the Lancet Commission for Sustainable Health Care.

Holger Schünemann is professor in the Departments of Health Research Methods. Evidence. and Impact and of Medicine. McMaster University. He received his MD and Dr. med. from Hannover Medical School and trained in lung biology. epidemioflogy. internal medicine and preventive medicine/public health at SUNY Buffalo (M.Sc. & Ph.D.). He is co-chair of the GRADE working group and director of Cochrane Canada and the McMaster GRADE center. Maintaining an active internal medicine practice fulfills his passion for patient care and ensures his guideline work is people-oriented. He is author of over 700 publications and among the 500 most cited scientists (www.webometrics.info).

Emily is specialised in the validity of preclinical research and has a background in pharmacology and neuroscience. Her interests are in the use of meta-research approaches to drive improvements in the validity. transparency and reproducibility of primary research using laboratory models of human diseases. Her work has informed laboratory practice guidelines. editorial policy and clinical trials design. Emily is a member of the University of Edinburgh Animal Welfare Ethical Review Board (AWERB) and convenor of CAMARADES. She also co-founded and was co-convenor of the University of Edinburgh Race Equality Network. now convenes the university’s Race Equality and Anti-Racist Sub-Committee and is highly committed to engendering and facilitating an anti-racist culture across campus.

Dr Karla Soares-Weiser is Editor in Chief at Cochrane. one of the world’s most trusted producers of health evidence. Leading Cochrane’s global network of over 100.000 people across 120 countries. Karla focuses on implementing the most effective. efficient and equitable ways to deliver the essential evidence people. governments and health organizations around the world need - now more than ever.

Throughout the Covid pandemic. Karla has overseen innovative organizational and editorial process improvements that ensured high quality evidence was produced rapidly and accessed freely around the world. Her enthusiasm for this work. along with previous roles in research. business and advocacy. reflect a lifelong practical commitment to improving global health and equity for all.

Karla has led and contributed to many multidisciplinary. multi-country teams producing and promoting trusted health and social care evidence for over 25 years. She has co-authored over 60 systematic reviews and is a keen contributor to health and policy forums around the world. Fluent in four languages. Karla also draws on a wealth of experience living and working in evidence synthesis and capacity building in different corners of the globe - including Brazil. Spain. the United Kingdom and Israel.

These personal and professional experiences combine to inform Karla’s authentic understanding of the complex geographic. cultural and socio-economic factors that impact health care and decision-making. They also inspire her ongoing focus on addressing critical evidence gaps. fostering diversity and inclusion. and creating genuine opportunities for researchers in low- and middle-income settings.

Karla graduated in Medicine and is board-certified psychiatrist. She holds a Masters in Mental Health Epidemiology and a Doctorate in Evidence-Based Health Care.

Per Olav Vandvik is a hospital-based internist and health research methodologist based in Oslo. Norway. He is also Professor of Medicine at the University of Oslo. His academic interests focus on evidence synthesis. appraisal. guideline methodology. dissemination. access and use at the point of care. to enhance evidence-based practice and shared decision- making.

Vandvik is co-founder and Chief Executive Officer of the MAGIC Evidence Ecosystem Foundation (MAGIC. www.magicevidence.org). a non-profit organization supporting development of digitally structured guidelines. evidence summaries and decision aids to clinicians and patients through the MAGIC online authoring and publication platform (www.magicapp.org). On behalf of MAGIC. he also co-steers the BMJ Rapid Recommendations. an international collaboration with the BMJ to accelerate evidence into practice through trustworthy recommendations. Within the context of the COVID-19 pandemic and infodemic. Vandvik and MAGIC is devoted to providing solutions to critical challenges with clinical practice guidelines. through trustworthy and living evidence and guidance. Under the leadership of Vandvik. MAGIC provides methodological support. MAGICapp and BMJ Rapid Recommendations for the WHO living guideline on COVID-19 drugs. Vandvik was a Trustee of the Board for the Guideline International Network (G-I-N) from 2014 until 2020 and has recently led their Webinar committee resulting in 4 presentations focused on the COVID-19 pandemic. He is also co-chair of the Working Group for Guidelines and HTA in COVID-END that involves more than 60 partner organisations.